Deutsche Bank Maintains Hold After Charles River Releases 2012 Guidance

Deutsche Bank has published a research report on Charles River Laboratories (NYSE: CRL) after the company released initial 2012 guidance this morning.

In the report, Deutsche Bank writes, "This morning, CRL provided its initial FY12 guidance. This included total top‐line growth of 2‐4% (0‐2% organic with 1% from Fx and 1% from having a 53rd week) and non‐GAAP EPS of $2.60‐$2.70. This is vs. the Street's current estimate of $2.66 and DB's current estimate of $2.65. From a top‐line perspective, we were modeling 1% organic growth, so this is also in line with our assumptions."

Deutsche Bank maintains it Hold rating and $32 price target on Charles River, which closed yesterday at $26.49.